Le Lézard
Classified in: Health, Business
Subject: PER

SVB Leerink Hires Robert Minear to Expand Healthcare Investment Banking Franchise


BOSTON, March 3, 2021 /PRNewswire/ -- SVB Leerink, a leading investment bank specializing in healthcare and life sciences, announced today that Robert Minear will join the firm's Healthcare Services and Technology Franchise team. Mr. Minear will be based in SVB Leerink's New York office and will report to Barry Blake, Global Co-Head of Investment Banking.

SVB Leerink announced that Robert Minear will join the firm's Healthcare Services and Technology Franchise team

Mr. Blake stated, "We are thrilled to welcome Rob to SVB Leerink, Rob's extensive network of financial sponsor relationships across markets will be critical to the success of our growing private equity and leveraged finance businesses."

Mr. Minear joins the firm as a Senior Managing Director focused on leading the firm's financial sponsor origination efforts to further enhance the firm's growing leveraged finance business.

"The firm warmly welcomes Rob to help drive our healthcare services and technology franchise," said Jim Boylan, Global Co-Head of Investment Banking. "Through his many deep relationships with private equity firms, we intend on building a market leading franchise to serve these firms with strategic ideas, M&A execution, and acquisition financing capabilities." 

Mr. Minear joins SVB Leerink from Guggenheim Securities where he was a Senior Managing Director in Healthcare investment banking, with a focus on advising companies in the healthcare services sector. Prior to his work at Guggenheim Securities, Mr. Minear was a Managing Director and Head of Healthcare Services Mergers and Acquisitions in Jefferies Group's Healthcare investment banking practice and a member of the M&A groups at UBS, both in New York and London, and Deutsche Bank.

"I am excited to join SVB Leerink as Senior Managing Director within the Investment Banking group," Mr. Minear shared. "Partnering with Barry, Jim, and the broader leadership team, I look forward to working with companies to find ways to finance innovations, provide strategic advice and ultimately effect transactions."

SVB Leerink will continue expanding its investment banking group with continued hiring efforts aimed at building a team dedicated to supporting Mr. Minear's private equity origination business.

About SVB Leerink
As the leading investment bank to the healthcare and life science industries, we help our clients move healthcare forward. With differentiated sector knowledge, unrivaled expertise, and a complete suite of capital market and advisory solutions, we are the industry's partner of choice. SVB Leerink is a wholly-owned subsidiary of SVB Financial Group and is a member of FINRA/SIPC. For more information, please visit: www.svbleerink.com.

SVB Leerink
Contact: Diane Vieira
(617) 918-4097

Weber Shandwick
Contact: Kaitlyn Rawlett
(212) 445-8082

SOURCE SVB Leerink


These press releases may also interest you

at 08:05
PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced that the Company will present at the BofA Securities 2021 Virtual Health Care Conference on Wednesday, May 12, 2021 at 9:30 a.m. ET. Prahlad Singh,...

at 08:05
The Termeer Foundation (www.termeerfoundation.org), a nonprofit organization focused on connecting life science innovators and catalyzing the creation of new medicines, today announced that the Class of 2021 Henri Termeer Fellowships have been named;...

at 08:05
Health2047 Inc., the Silicon Valley-based innovation subsidiary of the American Medical Association (AMA), has spun out portfolio company SiteBridge Research, Inc., which seeks to make clinical trials more accessible by empowering a broader set of...

at 08:05
Brii Biosciences (Brii Bio), Vir Biotechnology, Inc. , and VBI Vaccines Inc. today announced that the first patient has been dosed in a Phase 2 clinical trial evaluating BRII-835 (VIR-2218), an investigational small interfering ribonucleic acid...

at 08:05
PharmaEssentia Corporation (TPEx: 6446), a global biopharmaceutical innovator leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, has announced the appointment of Dr. Norio Komatsu, a...

at 08:04
Today the Insuretech, RecovX Health announced the next phase of its rollout out of their Universal Injury Claim Filing App, InjuryClaimsExpresstm. This version is the Insurance Company Personalized Web Portal for insurers who want to offer their own...



News published on 3 march 2021 at 06:00 and distributed by: